Article info

Original research
Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

Authors

  • Kazi J Nahar Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Robert V Rawson Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Tasnia Ahmed Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Stephen Tattersall Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Neomal Sandanayake Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Christopher J Kiely Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Serigne Lo Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Matteo Carlino Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Umaimainthan Palendira Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Richard A Scolyer Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Georgina V Long Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Alexander M Menzies Melanoma Institute Australia, North Sydney, New South Wales, Australia Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Alexander M Menzies; alexander.menzies{at}sydney.edu.au
View Full Text

Citation

Nahar KJ, Rawson RV, Ahmed T, et al
Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

Publication history

  • Accepted November 2, 2020
  • First published November 24, 2020.
Online issue publication 
November 24, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.